news Inhibiting REST gene could be clue to new diabetes treatments 12 August 2021 | By Anna Begley (Drug Target Review) A study has shown that inhibiting the REST gene boosted insulin-producing cells during early pancreas development in animals.
news New worm model could aid in the study of rare disease 21 February 2020 | By Rachael Harper (Drug Target Review) A new earthworm model has been developed for the rare disease, x-ALD, which the scientists say could lead to pharmacological targets for the neuronal alterations of the disease.
news Molecule of blood found to be effective against lupus 4 February 2020 | By Rachael Harper (Drug Target Review) Scientists have found that a molecule present in our blood, called C4BP (β-), could be used in a therapeutic capacity for lupus as well as potentially other autoimmune disorders.
news Function of protein involved in liver cancer discovered 30 October 2019 | By Rachael Harper (Drug Target Review) The involvement of clathrin in the development of liver cancer has been described for the first time, which could lead to more targeted therapy.
news New epigenetic drug against Mantle Cell Lymphoma 13 June 2018 | By Drug Target Review A new study presents an epigenetic drug capable of slowing down cell growth in Mantle Cell Lymphoma (MCL)...
news SB216763 shows preclinical efficacy in Rett syndrome 16 May 2018 | By Drug Target Review Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...